Overview: CatSper channels (CatSpers1–4; nomenclature as agreed by NC-IUPHAR, Clapham and Garbers, 2005) are putative 6TM, voltage-gated, calcium-permeant channels that are presumed to assemble as a tetramer of α-like subunits and mediate the current ICatSper. In mammals, CatSper subunits are structurally most closely related to individual domains of voltage-activated calcium channels (Cav) (Ren et al., 2001). CatSper1 (Ren et al., 2001), CatSper2 (Quill et al., 2001) and CatSpers3 and 4 (Lobley et al., 2003; Lin et al., 2005; Qi et al., 2007), in common with a recently identified putative 2TM-auxiliary CatSperβ protein (Liu et al., 2007) and a putative 1TM-associated CatSperγ protein (Wang et al., 2009), are restricted to the testis and localized to the principle piece of sperm tail.
| Nomenclature | CatSper1 | CatSper2 | CatSper3 | CatSper4 |
|---|---|---|---|---|
| Ensembl ID | ENSG00000175294 | ENSG00000166762 | ENSG00000152705 | ENSG00000188782 |
| Activators | Constitutively active, weakly facilitated by membrane depolarization, strongly augmented by intracellular alkalinization | – | – | – |
| Blockers | Cd2+ (200 μM), Ni2+ (300 μM), ruthenium red (10 μM) | – | – | – |
| Functional characteristics | Calcium-selective ion channel (Ba2+ > Ca2+ >> Mg2+ >> Na+); quasilinear monovalent cation current in the absence of extracellular divalent cations; alkalinization shifts the voltage dependence of activation towards negative potentials (V½ at pH 6.0 =+87 mV; V½ at pH 7.5 =+11 mV) | Required for ICatSper | Required for ICatSper | Required for ICatSper |
CatSper channel subunits expressed singly, or in combination, fail to functionally express in heterologous expression systems (Quill et al., 2001; Ren et al., 2001). The properties of CatSper1 tabulated above are derived from whole cell voltage-clamp recordings comparing currents endogenous with spermatozoa isolated from the corpus epididymis of wild-type and Catsper1(−/−) mice (Kirichok et al., 2006). ICatSper is also undetectable in the spermatozoa of Catsper2(−/−), Catsper3(−/−) or Catsper4(−/−) mice, and CatSper 1 associates with CatSpers2, 3 or 4 in heterologous expression systems (Qi et al., 2007). Moreover, targeted disruption of Catspers1, 2, 3 or 4 genes results in an identical phenotype in which spermatozoa fail to exhibit the hyperactive movement (whip-like flagellar beats) necessary for penetration of the egg cumulus and zona pellucida and subsequent fertilization. Such disruptions are associated with a deficit in alkalinization- and depolarization-evoked Ca2+ entry into spermatozoa (Carlson et al., 2003; 2005; Qi et al., 2007). Thus, it is likely that the CatSper pore is formed by a heterotetramer of CatSpers1–4 (Qi et al., 2007). CatSper channels are required for the increase in intracellular Ca2+ concentration in sperm evoked by egg zona pellucida glycoproteins (Xia and Ren, 2009). The driving force for Ca2+ entry is principally determined by a mildly outwardly rectifying K+ channel (KSper) that, like CatSpers, is activated by intracellular alkalinization (Navarro et al., 2007). KSper is not yet identified, but its properties are most consistent with mSlo3, a protein detected only in testis (Navarro et al., 2007).
Further Reading
Clapham DE, Garbers DL (2005). International Union of Pharmacology. L. Nomenclature and structure-function relationships of CatSper and two-pore channels. Pharmacol Rev57: 451–454.
Navarro B, Kirichok Y, Chung JJ, Clapham DE (2008). Ion channels that control fertility in mammalian spermatozoa. Int J Dev Biol52: 607–613.
Publicover SJ, Giojalas LC, Teves ME, de Oliveira GS, Garcia AA, Barratt CL et al. (2008). Ca2+ signalling in the control of motility and guidance in mammalian sperm. Front Biosci13: 5623–5637.
Quill TA, Wang D, Garbers DL (2006). Insights into sperm cell motility through sNHE and the CatSpers. Mol Cell Endocrinol250: 84–92.
Suarez SS (2008). Control of hyperactivation in sperm. Hum Reprod Update 14: 647–657.
Zhang D, Gopalakrishnan M (2005). Sperm ion channels: molecular targets for the next generation of contraceptive medicines? J Androl26: 643–653.
References
- Carlson AE, et al. Proc Natl Acad Sci USA. 2003;100:14864–14868. doi: 10.1073/pnas.2536658100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carlson AE, et al. J Biol Chem. 2005;280:32238–32244. doi: 10.1074/jbc.M501430200. [DOI] [PubMed] [Google Scholar]
- Kirichok Y, et al. Nature. 2006;439:737–740. doi: 10.1038/nature04417. [DOI] [PubMed] [Google Scholar]
- Lin J-L, et al. Biol Reprod. 2005;73:1235–1242. [Google Scholar]
- Liu J, et al. J Biol Chem. 2007;282:18945–18952. doi: 10.1074/jbc.M701083200. [DOI] [PubMed] [Google Scholar]
- Lobley A, et al. Reprod Biol Endocrinol. 2003;1:53. doi: 10.1186/1477-7827-1-53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Navarro B, et al. Proc Natl Acad Sci USA. 2007;104:7688–7692. doi: 10.1073/pnas.0702018104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Qi H, et al. Proc Natl Acad Sci USA. 2007;104:1219–1223. doi: 10.1073/pnas.0610286104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Quill TA, et al. Proc Natl Acad Sci USA. 2001;98:12527–12531. doi: 10.1073/pnas.221454998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ren D, et al. Nature. 2001;413:603–609. doi: 10.1038/35098027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang H, et al. Biol Reprod 2009. 2009;81:539–544. doi: 10.1095/biolreprod.109.077107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xia J, Ren D. Biol Reprod. 2009;80:1092–1098. doi: 10.1095/biolreprod.108.074039. [DOI] [PMC free article] [PubMed] [Google Scholar]
